Atlas Trials

Hengenix Biotech Inc

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hengenix Biotech Inc

RecordFirmDate
Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects (NCT04583228)Hengenix Biotech Inc2021-04-08
Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers (NCT04561076)Hengenix Biotech Inc2020-12-09

Track Hengenix Biotech Inc automatically

Every clearance here is in the API, with alerts when new ones post.